BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 11685128)

  • 1. [Spindle cell lipoma and 13q deletion: diagnostic utility of cytogenetic analysis].
    Dumollard JM; Ranchère-Vince D; Burel F; Coindre JM; Tallini G; Ligon AH; Mayaud R; Turc-Carel C; Martin C; Mosnier JF; Pedeutour F
    Ann Pathol; 2001 Aug; 21(4):303-10. PubMed ID: 11685128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence by spectral karyotyping that 8q11.2 is nonrandomly involved in lipoblastoma.
    Chen Z; Coffin CM; Scott S; Meloni-Ehrig A; Shepard R; Issa B; Forsyth DR; Sandberg AA; Brothman AR; Lowichik A
    J Mol Diagn; 2000 May; 2(2):73-7. PubMed ID: 11272891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [From cytogenetics to cytogenomics of adipose tissue tumors: 1. Benign adipose tissue tumors].
    Pedeutour F; Foa C
    Bull Cancer; 2002; 89(7-8):689-95. PubMed ID: 12206982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical lipomatous tumor with rare structural rearrangements involving chromosomes 8 and 12.
    Nilsson M; Domanski H; Mertens F; Mandahl N
    Oncol Rep; 2005 Apr; 13(4):649-52. PubMed ID: 15756437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosome 12 breakpoints are cytogenetically different in benign and malignant lipogenic tumors: localization of breakpoints in lipoma to 12q15 and in myxoid liposarcoma to 12q13.3.
    Mrózek K; Karakousis CP; Bloomfield CD
    Cancer Res; 1993 Apr; 53(7):1670-5. PubMed ID: 8453640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of retinoblastoma protein expression in spindle cell/pleomorphic lipomas and cytogenetically related tumors: an immunohistochemical study with diagnostic implications.
    Chen BJ; Mariño-Enríquez A; Fletcher CD; Hornick JL
    Am J Surg Pathol; 2012 Aug; 36(8):1119-28. PubMed ID: 22790852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between clinicopathological features and karyotype in lipomatous tumors. A report of 178 cases from the Chromosomes and Morphology (CHAMP) Collaborative Study Group.
    Fletcher CD; Akerman M; Dal Cin P; de Wever I; Mandahl N; Mertens F; Mitelman F; Rosai J; Rydholm A; Sciot R; Tallini G; van den Berghe H; van de Ven W; Vanni R; Willen H
    Am J Pathol; 1996 Feb; 148(2):623-30. PubMed ID: 8579124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rearrangement of chromosomal region 8q11-13 in lipomatous tumours: correlation with lipoblastoma morphology.
    Brandal P; Bjerkehagen B; Heim S
    J Pathol; 2006 Feb; 208(3):388-94. PubMed ID: 16308870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytogenetic profile of 109 lipomas.
    Sreekantaiah C; Leong SP; Karakousis CP; McGee DL; Rappaport WD; Villar HV; Neal D; Fleming S; Wankel A; Herrington PN
    Cancer Res; 1991 Jan; 51(1):422-33. PubMed ID: 1988102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromosomal changes detected by fluorescence in situ hybridization in patients with acute lymphoblastic leukemia.
    Zhang L; Parkhurst JB; Kern WF; Scott KV; Niccum D; Mulvihill JJ; Li S
    Chin Med J (Engl); 2003 Sep; 116(9):1298-303. PubMed ID: 14527352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of HMGI-C and HMGI(Y) in ordinary lipoma and atypical lipomatous tumors: immunohistochemical reactivity correlates with karyotypic alterations.
    Tallini G; Dal Cin P; Rhoden KJ; Chiapetta G; Manfioletti G; Giancotti V; Fusco A; Van den Berghe H; Sciot R
    Am J Pathol; 1997 Jul; 151(1):37-43. PubMed ID: 9212729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytogenetic and molecular cytogenetic findings in lipoblastoma.
    Bartuma H; Domanski HA; Von Steyern FV; Kullendorff CM; Mandahl N; Mertens F
    Cancer Genet Cytogenet; 2008 May; 183(1):60-3. PubMed ID: 18474299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoblastoma in a 23-year-old male: distinction from atypical lipomatous tumor using cytogenetic and fluorescence in-situ hybridization analysis.
    Sciot R; De Wever I; Debiec-Rychter M
    Virchows Arch; 2003 May; 442(5):468-71. PubMed ID: 12684772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spindle cell lipoma.
    Comunoglu N; Comunoglu C; Ekici AI; Ozkan F; Dervişoglu S
    Pol J Pathol; 2007; 58(1):7-11. PubMed ID: 17585537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NFIB rearrangement in superficial, retroperitoneal, and colonic lipomas with aberrations involving chromosome band 9p22.
    Italiano A; Ebran N; Attias R; Chevallier A; Monticelli I; Mainguené C; Benchimol D; Pedeutour F
    Genes Chromosomes Cancer; 2008 Nov; 47(11):971-7. PubMed ID: 18663748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the clinical and molecular impact of different cytogenetic subgroups in a series of 272 lipomas with abnormal karyotype.
    Bartuma H; Hallor KH; Panagopoulos I; Collin A; Rydholm A; Gustafson P; Bauer HC; Brosjö O; Domanski HA; Mandahl N; Mertens F
    Genes Chromosomes Cancer; 2007 Jun; 46(6):594-606. PubMed ID: 17370328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HMGIY is the target of 6p21.3 rearrangements in various benign mesenchymal tumors.
    Kazmierczak B; Dal Cin P; Wanschura S; Borrmann L; Fusco A; Van den Berghe H; Bullerdiek J
    Genes Chromosomes Cancer; 1998 Dec; 23(4):279-85. PubMed ID: 9824199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myofibroblastoma of the breast: genetic link with spindle cell lipoma.
    Pauwels P; Sciot R; Croiset F; Rutten H; Van den Berghe H; Dal Cin P
    J Pathol; 2000 Jul; 191(3):282-5. PubMed ID: 10878550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two genetic pathways, t(1;10) and amplification of 3p11-12, in myxoinflammatory fibroblastic sarcoma, haemosiderotic fibrolipomatous tumour, and morphologically similar lesions.
    Hallor KH; Sciot R; Staaf J; Heidenblad M; Rydholm A; Bauer HC; Aström K; Domanski HA; Meis JM; Kindblom LG; Panagopoulos I; Mandahl N; Mertens F
    J Pathol; 2009 Apr; 217(5):716-27. PubMed ID: 19199331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorescence in situ hybridization improves the detection of 5q31 deletion in myelodysplastic syndromes without cytogenetic evidence of 5q-.
    Mallo M; Arenillas L; Espinet B; Salido M; Hernández JM; Lumbreras E; del Rey M; Arranz E; Ramiro S; Font P; González O; Renedo M; Cervera J; Such E; Sanz GF; Luño E; Sanzo C; González M; Calasanz MJ; Mayans J; García-Ballesteros C; Amigo V; Collado R; Oliver I; Carbonell F; Bureo E; Insunza A; Yañez L; Muruzabal MJ; Gómez-Beltrán E; Andreu R; León P; Gómez V; Sanz A; Casasola N; Moreno E; Alegre A; Martín ML; Pedro C; Serrano S; Florensa L; Solé F
    Haematologica; 2008 Jul; 93(7):1001-8. PubMed ID: 18591625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.